glp 1 agonist wegovy Wegovy® is now accessible to eligible Medicare beneficiaries living with obesity through Medicare GLP-1 Bridge Is GLP-1 Safe for Weight

While their glycemic, weight-lowering, and cardiovascular benefits are well established through randomized trials and meta-analyses, concerns remain regarding their safety and tolerability across diverse populations and clinical settings

From a scientific breakthrough studying the oft fasting Gila Monster has become the current successful weight loss therapies, here's how.

All bases covered

Discover the science behind Wegovy and how GLP-1 technology helps reduce appetite, improve metabolism, and support long-term weight loss

Glucagon-like peptide-1 (GLP-1) is an incretin peptide hormone mainly secreted by enteroendocrine intestinal L-cells